Abdul’s research focused on DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL SELECTIVE CANNABINOID RECEPTOR 2 (CB2) LIGANDS WITH THERAPEUTIC POTENTIALS.  CB2 receptors has been shown to be involved in several physiological functions as well as diseases, such as pain, multiple sclerosis, osteoporosis, and cancer treatment demonstrating the importance of the CB2 receptors. Dr.  Abdulrahman A Almehizia has employed chemistry design and discovery to identify novel CB2 ligands, carried out in-vitro functional studies, and tested their therapeutic potentials.  We will sorely miss his intelligence, enthusiasm in the lab.    Best wishes to Abdul in all of his endeavors!